Suchergebnisse - "Cappello, Maria"

PubPharm (162)

41

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

enthalten in: Journal of gastroenterology and hepatology | 2021

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +19

42

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection : an IG‐IBD study

enthalten in: Alimentary Pharmacology & Therapeutics | 2021

von Bezzio, C. | Armuzzi, A. | Furfaro, F. | +22

43

Ustekinumab in Crohn's disease : Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

enthalten in: JGH Open | 2021

von Viola, A. | Muscianisi, M. | Macaluso, F. | +17

44

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

enthalten in: Journal of Gastroenterology and Hepatology | 2021

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +18

45

SPOSAB ABP 501 : A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

enthalten in: Journal of Gastroenterology and Hepatology | 2021

von Macaluso, F. | Cappello, M. | Busacca, A. | +22

46

Two‐year effectiveness and safety of golimumab in ulcerative colitis : An IG‐IBD study

enthalten in: United European Gastroenterology Journal | 2021

von Pugliese, D. | Privitera, G. | Rogai, F. | +28

47

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +20

48

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy : How to maintain standards of care

enthalten in: United European gastroenterology journal | 2020

von Saibeni, S. | Scucchi, L. | Dragoni, G. | +44

49

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy : Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

enthalten in: Expert opinion on biological therapy | 2020

von Macaluso, F. | Fries, W. | Viola, A. | +19

50

Effectiveness and safety of vedolizumab in biologically naïve patients : A real-world multi-centre study

enthalten in: United European gastroenterology journal | 2020

von Macaluso, F. | Fries, W. | Renna, S. | +17